US 8,655,454 B2Grant

Targeted cooling of deployable microwave antenna with cooling chamber

Issue Date:2014-02-18

•14 Claims

•12 Drawing Sheets

Abstract

The present disclosure relates to devices and methods for the treatment of tissue with microwave energy. The devices and methods disclosed herein utilize an antenna assembly which includes an elongate member, an outer conductor, an inner conductor, at least a portion of which is deployable, and a cooling system. The cooling system disclosed herein may significantly curtail any theoretical, or potential negative effects upon the target tissue experienced during the transmission of microwave energy to the antenna assembly due to ohmic heating.

Metadata

Assignee

Covidien LP

Inventors

Mani N. Prakash
Tao Nguyen
Christopher T. Rusin

Application Information

Application Number:US 13/945,519

Filing Date:2013-07-18

Priority Date:2007-11-27

Art Unit:3739

Classifications

IPC:

A61F2/00A61B18/04A61B18/18

Patent Drawings (12 sheets)

Description

Cross-Reference to Related Applications

[0001] This application is a continuation of U.S. patent application Ser. No. 13/657,609, filed Oct. 22, 2012, now U.S. Pat. No. 8,491,580, which is a continuation of U.S. patent application Ser. No. 12/277,951, filed Nov. 25, 2008, now U.S. Pat. No. 8,292,880, which claims the benefit of and priority to U.S. Provisional Patent Application Ser. No. 60/990,350, filed Nov. 27, 2007, the entire contents of all of which is hereby incorporated by reference herein.

Background

[0002] 1. Technical Field

[0003] The invention relates generally to microwave antennas that may be used in therapeutic or ablative tissue treatment applications. More particularly, the invention relates to devices and methods for regulating, maintaining, and/or controlling a temperature of microwave antennas used in such applications.

[0004] 2. Background of the Related Art

[0005] Many procedures and devices employing microwave technology are well known for their applicability in the treatment, coagulation, and targeted ablation of tissue. During such procedures, the antenna of a microwave probe of the monopole, dipole, or helical variety, as is conventional in the art, is typically advanced into the patient either laparoscopically or percutaneously until the target tissue is reached.

[0006] Following the introduction of the microwave probe, during the transmission of microwave energy to the target tissue, the outer surface of the antenna may sometimes reach unnecessarily high temperatures due to ohmic heating. When exposed to such temperatures, the treatment site, as well as the surrounding tissue, may be unnecessarily and unintentionally effected. The present disclosure contemplates curtailing such tissue effects by providing improved microwave tissue treatment devices, cooling systems, and methods.

[0007] To prevent such unnecessarily high temperatures, several different cooling methodologies are conventionally employed.

Summary

[0008] A need exists in the art for an improved microwave tissue treatment device incorporating a cooling or temperature control system that minimizes unnecessarily high temperatures during tissue treatment.

[0009] The present disclosure is directed to a microwave tissue treatment device for the therapeutic treatment or ablation of tissue. In one embodiment, a microwave tissue treatment device is disclosed that includes an antenna assembly having an elongate member with proximal and distal ends that defines a longitudinal axis, outer and inner conductors disposed within the elongate member that extend along the longitudinal axis, a dielectric material interposed between the outer and inner conductors, and a sleeve at least partially disposed about a distal portion of the inner conductor and defining a cavity therearound, the cavity having a proximal end and a distal end. At least a portion of the inner conductor is deployable such that the antenna assembly may transition from a first position to a second position. The device also includes a cooling system associated with the antenna assembly that includes at least one inflow member and at least one outflow member, each of which is configured to circulate at least one fluid within the cavity such that at least a section of the inner conductor is in fluid contact therewith.

[0010] The cavity defined by the sleeve may include at least two regions, such as, for example, a proximal region, an intermediate region, and a distal region. In one embodiment, the microwave tissue treatment device includes at least one baffle member for defining at least two regions of the cavity. In another embodiment, the at least one baffle member defines at least two axial dimensions within the cavity.

[0011] In yet another embodiment, the microwave tissue treatment device cooling system includes first, second, and third inflow and outflow members, the first inflow and outflow members, the second inflow and outflow members, and the third inflow and outflow members being in fluid communication with a respective proximal, intermediate, and distal regions of the cavity defined by the sleeve.

[0012] The microwave tissue treatment device may include at least one temperature sensor operatively connected to the cavity, or a region thereof.

[0013] In another embodiment, the microwave tissue treatment device includes a first baffle member and a second baffle member disposed within the cavity. The first baffle member and the proximal end of the cavity define a proximal region of the cavity of the sleeve, the first baffle member and the second baffle member define an intermediate region of the cavity, and the second baffle member and the distal end of the cavity define a distal region of the cavity. The first baffle member is configured to substantially prevent the communication of fluid between the proximal and intermediate regions, while the second baffle member is configured to substantially prevent the communication of fluid between the intermediate region and the distal region. The first baffle member and the proximal end of the cavity define a first axial dimension, while the first baffle member and the second baffle member define a second axial dimension, and the second baffle member and the distal end of the cavity define a third axial dimension. In one embodiment, the first axial dimension is greater than the second axial dimension.

[0014] In another embodiment, the proximal region of the cavity has a first internal diameter, and the intermediate and distal regions have second and third internal diameters, respectively. In one embodiment, the first internal diameter is greater than the second internal diameter, and the second internal diameter is greater than the third internal diameter.

[0015] In one embodiment of the present disclosure, at least a portion of the inner conductor has a substantially arcuate profile when deployed, whereas in an alternate embodiment, at least a portion of the inner conductor has a substantially non-arcuate profile when deployed. In another embodiment, at least a portion of the inner conductor has a substantially tapered profile.

[0016] The fluid may be chosen from the group consisting of water, saline, ammonium chloride, sodium nitrate, and potassium chloride, and the fluid may be circulated with a pump.

[0017] According to another aspect of the present disclosure, an improved microwave tissue treatment device is disclosed that includes an antenna assembly having an outer conductor and an inner conductor with a dielectric material interposed therebetween, where at least a portion of the inner conductor is deployable. The device also includes a sleeve that is at least partially disposed about a distal portion of the inner conductor, thereby defining at least one cavity, at least one baffle member disposed within the sleeve such that at least two regions of the cavity is defined, and a cooling system. The cooling system includes at least one inflow member and at least one outflow member, each of which is in fluid communication with the cavity defined by the sleeve.

[0018] According to a further aspect of the present disclosure, a method of cooling a microwave antenna includes providing a cooling system including at least one inflow and outflow member, each being in fluid communication with at least a portion of the microwave antenna, and flowing a cooling fluid through the cooling system such that the cooling fluid is in fluid communication with at least a portion of the microwave antenna.

[0019] These and other features of the microwave tissue treatment device and method of use disclosed herein will become more readily apparent to those skilled in the art from the following detailed description of various embodiments of the present disclosure.

Brief Description of the Drawings

[0020] Various embodiments of the present disclosure are described hereinbelow with references to the drawings, wherein:

[0021] FIG. 1 is a schematic illustration of a microwave tissue treatment system including a microwave tissue treatment device, in accordance with an embodiment of the present disclosure;

[0022] FIG. 2A is a transverse, cross-sectional view of a feedline of the microwave tissue treatment device of FIG. 1, as taken through 2A-2A of FIG. 1;

[0023] FIG. 2B is a longitudinal, cross-sectional view of the feedline of the microwave tissue treatment device of FIG. 1, as taken through 2B-2B of FIG. 1;

[0024] FIG. 3 is a perspective view of an antenna assembly of a microwave tissue treatment device, in accordance with an embodiment of the present disclosure, shown in a non-deployed condition;

[0025] FIG. 4 is a perspective view of the antenna assembly of FIG. 3, shown in a deployed, linear condition;

[0026] FIG. 5 is a perspective view of an antenna assembly of a microwave tissue treatment device, in accordance with an embodiment of the present disclosure, shown in a deployed, arcuate condition;

[0027] FIG. 6 is a perspective view of an antenna assembly of a microwave tissue treatment device, in accordance with another embodiment of the present disclosure, shown in a deployed condition;

[0028] FIG. 7 is a perspective view of an antenna assembly of a microwave tissue treatment device in accordance with another embodiment of the present disclosure, shown in a deployed condition;

[0029] FIG. 8 is a perspective view of an antenna assembly of a microwave tissue treatment, including a cooling system, according to one embodiment of the present disclosure;

[0030] FIG. 8A is a perspective view of an antenna assembly of a microwave tissue treatment, including a cooling system, according to another embodiment of the present disclosure;

[0031] FIG. 8B is a perspective view of an antenna assembly of a microwave tissue treatment device, including a cooling system, according to still another embodiment of the present disclosure;

[0032] FIG. 8C is a perspective view of an antenna assembly of a microwave tissue treatment device, including a cooling system, according to yet another embodiment of the present disclosure;

[0033] FIG. 8D is a front view of the antenna assembly of FIG. 8C;

[0034] FIG. 9 is a side, plan view of an antenna assembly of a microwave tissue treatment device in accordance with another embodiment of the present disclosure;

[0035] FIG. 10 is a side, plan view of an antenna assembly of a microwave tissue treatment device in accordance with yet another embodiment of the present disclosure;

[0036] FIG. 11 is a perspective view of an antenna assembly of a microwave tissue treatment device in accordance with another embodiment of the present disclosure, shown in a deployed condition; and

[0037] FIG. 12 is a side, plan view of an antenna assembly of a microwave tissue treatment device in accordance with another embodiment of the present disclosure.

Detailed Description of the Embodiments

[0038] In the drawings and in the description that follows, the term “proximal”, as is traditional, will refer to the end of the apparatus that is closest to the clinician, while the term “distal” will refer to the end that is furthest from the clinician.

[0039] Referring now in detail to the figures, in which like references numerals identify similar or identical elements, there is illustrated, in FIG. 1, a microwave tissue treatment system 10 in accordance with the present disclosure. System 10 includes a microwave tissue treatment device 1000 having an antenna assembly 100 connected to a power source or supply 20, e.g. a microwave or RF generator or any suitable power generating device suitable for energizing the tissue treatment device 1000, through a feedline 30. Microwave tissue treatment device 1000 may include a pump 40, e.g. a peristaltic pump or the like, as a mechanism for circulating a cooling or heat dissipative fluid through device 1000, as described below. Device 1000 may further include a pusher or deployment assembly 50 that includes a deployment knob 52, where deployment knob 52 is operatively engaged with or coupled to the antenna assembly 100, as described in further detail below.

[0040] Referring now to FIGS. 1-2B, as indicated above, device 1000 is electrically connected to generator or power supply 20 by feedline 30. Feedline 30 may be any suitable conductive pathway capable of transferring an electrical current to tissue treatment device 1000. In one embodiment, as seen in FIGS. 2A-2B, feedline 30 may be a coaxial cable composed of an inner conductor 102, an outer conductor 104, and a dielectric 106 interposed between inner and outer conductors 102, 104 to electrically separate and/or isolate inner and outer conductors 102,104 from one another. Inner and outer conductors 102, 104 may each be made of a suitable conductive material that may be semi-rigid or flexible, while dielectric 106 may include any number of suitable non-conductive materials such as ceramic and polytetrafluoroethylene (PTFE). Inner and outer conductors 102, 104 of feedline 30 may incorporate any suitable conductive material or metal, including, but not limited to, silver, copper and gold. In certain embodiments, inner and outer conductors 102, 104 of feedline 30 may include a conductive or non-conductive substrate plated or coated with a suitable conductive material.

[0041] Feedline 30 may range in length from about 1 foot (0.3048 m) to about 15 feet (4.572 m), or greater, if required in a particular application. As depicted in FIG. 1, feedline 30 has a proximal portion 108 operatively connected to, or connectable to, power supply 20 at proximal end 110, and a distal portion 112 that forms a part of microwave tissue treatment device 1000, as disclosed below.

[0042] Referring now to FIGS. 1, 3 and 4, microwave tissue treatment device 1000 includes an antenna assembly 100 having an elongate member 114 disposed about a distal portion 112 of feedline 30, and a sleeve 116 that at least partially surrounds a distal portion 102a of the inner conductor, as described in further detail below.

[0043] Elongate member 114 has proximal and distal ends 118, 120 and defines longitudinal axis “A”. Elongate member 114 may be formed of any material suitable for electrically insulating a clinician or operator from the inner and outer conductors 102, 104 of feedline 30 disposed therein such that the antenna assembly 100 may be handled during use.

[0044] Elongate member 114 conceals a distal portion 102a (FIG. 3) of the inner conductor 102 when the microwave tissue treatment device 1000 is not in use so as to prevent unintentional damage or injury, as well as the distal portion 112 of feedline 30, which includes distal portions 102a, 104a, and 106a of the inner conductor, the outer conductor, and the dielectric, respectively. Accordingly, the inner conductor, the outer conductor, and the dielectric are not only components of the feedline 30, but also constitute components of antenna assembly 100.

[0045] At least a portion of the inner conductor, i.e. distal portion 102a, is deployable from distal portion 104a of the outer conductor, such that the antenna assembly 100 may transition from a first, non-deployed condition (FIG. 3), to a second, deployed condition during use (FIG. 4), as described in further detail below. In the first condition, the distal portion 102a of the inner conductor is at least partially disposed within the distal portion 104a of the outer conductor and the elongate member 114. In the second, deployed condition, the distal portion 102a of the inner conductor extends at least partially beyond a distal end 120 of elongate member 114, such that contact may be made with the target tissue (not shown).

[0046] Movement from the first position to the second position may be facilitated through the use of any suitable mechanism, such as, for example, a deployment assembly 50 (FIG. 1). Reference may be made to commonly owned U.S. Patent Publication No. 2004/0267156, filed Apr. 4, 2004, for a detailed discussion regarding the components and functionality of deployment assembly 50.

[0047] In one embodiment, as seen in FIG. 4, antenna assembly 100 includes a distal portion 102a of an inner conductor that exhibits a substantially non-arcuate profile when deployed. In an alternate embodiment, as seen in FIG. 5, antenna assembly 200 includes an inner conductor with a distal portion 202a that exhibits a substantially arcuate profile when deployed. Reference may be made to commonly owned U.S. Pat. No. 7,197,363 for a detailed discussion of the structure of arcuate microwave antenna configurations.

[0048] In another embodiment, as seen in FIG. 6, antenna assembly 300 includes a distal portion 302a of an inner conductor that is not entirely formed of a conductive material. In this embodiment, distal portion 302a of the inner conductor includes a radiating member 324 with one or more conductive surfaces 326. Conductive surface or surfaces 326 may have a particular pattern or distribution for focusing or dispersing the energy transmitted into distal portion 302a of the inner conductor. For example, radiating member 324 may have a conductive surface 326 on only one side or in one particular area or region thereof.

[0049] Referring back to FIGS. 3 and 4, sleeve 116 is disposed about distal portion 102a of the inner conductor in such a manner so as to define a cavity 128. Sleeve 116 may be fixedly, releasably, or slidably connected to distal portion 102a in any suitable manner including, but not being limited to, welding or adhering, as would be appreciated by one skilled in the art. Sleeve 116 has proximal and distal ends 130, 132 defined by the points at which sleeve 116 is connected to distal portion 102a. In one embodiment, as best seen in FIG. 4, the distal-most tip 134 of distal portion 102a extends beyond the distal end 132 of sleeve 116. In another embodiment, however, as best seen in FIG. 7, antenna assembly 400 may include a sleeve 416 connected to a distal portion 402a of an inner conductor at the distal-most tip 434 thereof, or at a point therebeyond (not shown).

[0050] Referring again to FIGS. 3 and 4, proximal end 130 of sleeve 116 may be located at any suitable location along the length of distal portion 102a of the inner conductor, dependent upon the desired volume of cavity 128. Although depicted as substantially incisive, the present disclosure contemplates that distal-most tip 134 may be substantially arcuate, duckbilled, or any other such configuration suitable for facilitating the entry of the microwave tissue treatment device into the tissue of a patient.

[0051] Sleeve 116 may be formed of any suitable biocompatible, impermeable material capable of retaining fluid therein, including and not limited to PTFE and tetrafluorethylene-perfluorpropylene (FEP). The present disclosure contemplates that sleeve 116 may be either substantially rigid, or substantially non-rigid in character.

[0052] In one embodiment, as seen in FIG. 8, antenna assembly 500 includes a sleeve 516 defining a cavity 528 around a distal portion 502a of an inner conductor, and one or more baffle member(s) 542, 544 disposed within sleeve 516 that function to divide or compartmentalize cavity 528 into individual regions 536, 538, 540. Each region 536, 538, 540 defines a respective section 546, 548, 550 of the distal portion 502a of the inner conductor. In an alternate embodiment, as seen in FIG. 8A, the individual regions 536, 538, 540 are not defined by physical baffle members 542, 544 (FIG. 8), but are rather defined constructively as virtual baffle members 542_A, 544_Aby the interaction of a corresponding number of fluids, e.g. one fluid within each of individual regions 536, 583, 540, which may be immiscible. The incorporation of one or more fluids into antenna assembly 500 will be discussed in further detail below.

[0053] First or proximal region 536 and first section 546 of distal portion 502a have a first axial dimension L₁, and are defined by the location of the proximal end (not shown) of the sleeve 516 and the location of first baffle member 542. Second or intermediate region 538 and second section 548 of distal portion 502a have a second axial dimension L₂, and are defined by the location of first baffle member 542 and the location of second baffle member 544. And third or distal region 540 and third section 550 of distal portion 502a have a corresponding third axial dimension L₃, and are defined by the location of second baffle member 544 and the location of distal end 532 of sleeve 516.

[0054] In this embodiment, first and second baffle members 542, 544, respectively, serve not only to define the metes of the three regions 536, 538, 540 of cavity 528 of sleeve 516, in conjunction with the proximal end 528 (not shown) and the distal end 530 thereof, but also serve to substantially prevent any co-mingling of cooling fluid or fluids that may be circulated throughout each of the proximal, intermediate, and distal regions 536, 538, 540, as described below. The present disclosure contemplates that cavity 528 of sleeve 516 may be divided into any suitable number of regions dependent upon the requirements of the procedure and the application in which the microwave tissue treatment device may be employed.

[0055] With continued reference to FIG. 8, third or distal section 550 of the distal portion 502a of the inner conductor may comprise the area of active heating during tissue treatment or ablation. It may be desirable, therefore, to prevent the temperature in distal section 550 from reaching excessively high temperatures in order to maintain optimal energy delivery and to maintain optimal thermal therapy of the tissue. Second or intermediate section 548 of distal portion 502a may also become hot due to ohmic and conductive heating from distal section 550. Since intermediate section 548 may be in contact with the tissue surrounding the target site, it may be desirable to allow intermediate section 548 to achieve a particular temperature profile dependent upon the procedure in which the antenna assembly 500 is employed.

[0056] As an illustrative example, where coagulation of the insertion tract may be desirable, the clinician may want to allow intermediate section 548 of distal portion 502a of the inner conductor to attain a particular predetermined temperature capable of creating a coagulating effect in the insertion tract. In other applications, it may also be desirable, however, to prevent the temperature in intermediate section 548 from rising beyond a particular threshold to protect surrounding sensitive tissue structures from undesired effects. During use, first or proximal section 546 of distal portion 502a may also come into contact with the skin of a patient. Accordingly, since proximal section 546 of distal portion 502a may also be subject to ohmic and/or conductive heating, it may therefore be desirable to maintain the temperature of this section below a specific temperature, particularly in percutaneous or laparoscopic procedures, to prevent undesired effects upon the skin surface of the patient. In other procedures, such as in applications where lesions are located deep within the tissue, it may be desirable to allow the proximal section 546 to become heated to allow for the coagulation of the insertion tract.

[0057] With continued reference to FIG. 8, antenna assembly 500 further includes a cooling system 552 for regulating the temperature of distal portion 502a of the inner conductor. The cooling system 552 operates in conjunction with, and is fluidly connected to, cavity 528 of sleeve 516 such that one or more cooling or heat dissipative fluids “F” may be circulated therethrough. Fluid “F” serves to dissipate some of the heat generated by the antenna assembly 500 during use and may also act as a medium that modifies the dielectric constant of the distal portion of the antenna assembly. Potential dissipative fluids include, but are not limited to, water, saline, liquid chlorodifluoromethane, or any suitable perfluorocarbon fluid, such as Fluorinert®, distributed commercially by Minnesota Mining and Manufacturing Company (3M™), St. Paul, Minn., USA. The fluid circulated through cooling system 552 may vary depending upon the desired cooling rate and the desired tissue impedance matching properties. In various embodiments, gases, such as air, nitrous oxide, nitrogen, carbon dioxide, etc., may also be utilized as the dissipative fluid. In yet another variation, a combination of liquids and/or gases may be utilized.

[0058] During circulation, the heat dissipative fluid is in contact with those sections 546, 548, 550 of distal portion 502a of the inner conductor within respective regions 536, 538, 540 of cavity 528 defined by sleeve 516 such that the heat generated therein may be dissipated through the fluid “F”. The cooling system 552 includes one or more inflow tubes 554, 556, 558, and one or more respective outflow tubes 560, 562, 564 to circulate the dissipative fluid “F”. Cooling system 552 may also include at least one pump 40 (FIG. 1) in fluid communication with each inflow tube 554, 556, 558 and each outflow tube 560, 562, 564 for facilitating the circulation of the dissipative fluid “F”.

[0059] Cooling system 552 may include any number of inflow and outflow tubes suitable for circulating a dissipative fluid throughout the cavity 528 defined by sleeve 516, and/or any individual regions thereof. Cooling system 552 may also employ any number of inflow and outflow members in fluid communication with each section 546, 548, 550 of distal portion 502a of the inner conductor. In some embodiments, one or more regions of cavity 528 may not be in fluid communication with cooling system 552.

[0060] As seen in FIG. 8, each of the proximal, intermediate, and distal regions 536, 538, 540, respectively, has a corresponding inflow tube 554, 556, and 558 in fluid communication therewith, and a corresponding outflow tube 560, 562, and 564 in fluid communication therewith. In particular, a proximal end (not shown) of first inflow tube 554 may be connected to pump 40 (FIG. 1), while a distal end 566 of first inflow tube 554 is in fluid communication with proximal region 536, thereby allowing dissipative fluid to flow, either constantly or intermittently, into the proximal region 536 of cavity 528 defined by sleeve 516. Upon entering proximal region 536, the dissipative fluid “F” comes into direct contact with the proximal section 546 of distal portion 502a of the inner conductor, allowing for the direct convective cooling of proximal section 546. In conjunction with first inflow tube 554, a proximal end (not shown) of first outflow tube 560 may be connected to pump 40 (FIG. 1), while a distal end 572 of first outflow tube is in fluid communication with proximal region 536, thereby allowing the dissipative fluid “F” to flow, either constantly or intermittently, out of the proximal region 536, and return to the pump 40 (FIG. 1). In so doing, during operation, heat generated by proximal section 546 of distal portion 502a of the inner conductor, disposed within the proximal region 536 of the cavity 528 defined by sleeve 516, may be regulated and/or dissipated.

[0061] As with the proximal region 536, a dissipative fluid may be pumped into and out of intermediate region 538 through respective distal ends 568, 574 of the second inflow and outflow tubes 556, 562 thereby dissipating the heat generated by the intermediate section 548 of distal portion 502a of the inner conductor through the fluid circulated therein.

[0062] Likewise, a dissipative fluid may also be circulated into and out of the distal region 540 through respective distal ends 570, 576 of the third inflow and outflow tubes 558, 564 thereby dissipating the heat generated by the distal section 550 of distal portion 502a of the inner conductor through the fluid circulated therein. In some embodiments, the fluid may act as a medium that modifies the dielectric constant of the antenna.

[0063] With continuing reference to FIG. 8, inflow tubes 554, 556, 558 may enter cavity 528 through apertures (not shown) at the proximal end of sleeve 516 (not shown). First inflow tube 554 and first outflow tube 560 are configured such that their respective distal ends 568, 580 are in fluid communication with proximal region 536. Second and third inflow tubes 556, 558 and second and third outflow tubes 562, 564 may continue through proximal region 536, through apertures 590 in first baffle member 542, and into intermediate region 538. Second inflow tube 556 and second outflow tube 562 are configured such that their respective distal ends 572, 584 are in fluid communication with intermediate region 538. Third inflow and outflow tubes 558, 564 continue through intermediate region 538, through apertures 590 in second baffle member 544, and into distal region 540. Third inflow and outflow tubes 558, 564 are configured such that their respective distal ends 576, 588 are in fluid communication with distal region 540.

[0064] In this embodiment, each of the proximal end of the cavity 528, the first baffle member 542, and the second baffle member 544 include seal members 592 associated with apertures 590. Seal members 592 may be any member suitable to substantially prevent the escape of any fluid contained within respective regions of cavity 528, through the apertures 590, including, and not limited to a seal, gasket, or the like. Seal members 592 may be formed of any suitable material, including and not limited to, a polymeric material. Seal members 592 may also substantially prevent the intermingling of the cooling fluids circulated through each of the proximal, intermediate, and distal regions 536, 538, 540 of cavity 528.

[0065] Referring momentarily to FIG. 8B, antenna assembly 600 includes a cooling system 652 having inflow tubes 654, 656, 658 and outflow tubes 660, 662, 664. In this embodiment, inflow tubes 654, 656, 658 and outflow tubes 660, 662, 664 enter cavity 628 defined by sleeve 616 through apertures 690 formed therein. In this embodiment, inflow tubes 654, 656, 658 may traverse elongate member 614 along its outer surface, connecting to either a common pump 40 (FIG. 1), or to individual pumps, as described above. Correspondingly, outflow tubes 660, 662, 664 may also traverse the outer surface of elongate member 116, connecting to either the common pump 40 (FIG. 1) or to the individual pumps. In this embodiment, sleeve 616 is adapted with sealing member or members 692 at apertures 690 to substantially prevent the escape of any fluid contained in cavity 628 defined by sleeve 616 through apertures 690.

[0066] In another embodiment, as seen in FIGS. 8C-8D, antenna assembly 600 may include one or more channels 694 formed in the elongate member 614 that are configured to respectively receive at least a portion of inflow tubes 654, 656, 658 and outflow tubes 660, 662, 664. Alternatively, channels 694 may be formed in outer conductor 604, dielectric material 606, or in any other suitable location.

[0067] Referring again to FIG. 8, given the desirability of controlled heating and temperature regulation within the individual sections 546, 548, and 550 of distal portion 502a of the inner conductor and the corresponding regions 536, 538, and 540 of the cavity 528, the axial locations of first and second baffle members 542, 544 within cavity 528 may be varied as desired or necessary. By varying the location of baffle members 542 and 544 in different embodiments, the axial length of the proximal, intermediate and distal regions 536, 538, and 540 may be varied. In varying the axial length of a region, the overall volume of that region may be varied, and accordingly, the volume of dissipative fluid circulated within that region may also be varied. As would be appreciated by one of ordinary skill in the art, an inverse relationship exists between the volume of dissipative fluid within a particular region of the cavity 528 and the temperature of that region, in that as the volume of fluid is increased, the temperature of the region will decrease. As an additional means of regulating temperature, the flow rate of fluid “F” into each regions 536, 538, and 540 of the cavity 528 may be controlled or varied, e.g. through the use of multiple pumps (not shown).

[0068] The baffle members 542, 544 may be located at any suitable or desired point within the cavity 528 defined by the sleeve 516. In one embodiment, baffle members 542, 544 are positioned such that the first, second and third axial dimensions, L₁, L₂, and L₃, respectively, of proximal, intermediate, and distal regions 536, 538, 540 are substantially equivalent. In another embodiment, baffle members 542, 544 are positioned such that the first axial dimension L₁, of proximal region 536, is greater than the second and third axial dimensions L₂and L₃, respectively, of intermediate and distal regions 538, 540. In yet another embodiment, baffle members 542, 544 are positioned such that the third axial dimension L₃, of distal region 540, is greater than the first and second axial dimensions L₁and L₂, respectively, of proximal and intermediate regions 536, 538. In alternate embodiments, the present disclosure contemplates locating the baffle members 542, 544 such that the overall volume of the cavity 528 may be distributed amongst any individual regions thereof in any suitable manner.

[0069] Referring now to FIGS. 9 and 12, in other embodiments, antenna assembly 700 includes a sleeve 716 that defines a cavity 728 having proximal, intermediate, and distal regions 736, 738, and 740 defined by first and second baffle members 742, 744. In this embodiment, proximal, intermediate, and distal regions 736, 738, and 740 have a first, a second, and a third radial dimension or diameter D₁, D₂, and D₃, respectively. In accordance with the present disclosure, radial dimensions D₁, D₂, and D₃of the proximal, intermediate, and distal regions 736, 738, and 740 may be varied so as to control the volume of each region, and accordingly, the volume of dissipative fluid circulated therethrough. By varying the volume of dissipative fluid circulated through each individual region 736, 738, and 740 of the cavity 728, the temperature of each region may be substantially regulated, as discussed above.

[0070] In one embodiment, the first, second and third radial dimensions, D₁, D₂, and D₃, respectively, are substantially equivalent. In another embodiment, as illustrated in FIG. 9, the first radial dimension D₁, of proximal region 736, is greater than the radial dimensions D₂and D₃, respectively, of intermediate and distal regions 738 and 740. In yet another embodiment, as illustrated in FIG. 12, the third radial dimension D₃, of distal region 740, is greater than the radial dimensions D₁and D₂, respectively, of proximal and intermediate regions 736 and 738. In alternate embodiments, the present disclosure contemplates that the radial dimensions D₁, D₂, and D₃, respectively, of each region 736, 738, and 740 of the cavity 728 defined by the sleeve 716, may be varied in any suitable manner.

[0071] Referring now to FIG. 10, in one embodiment, the present disclosure contemplates an antenna assembly 800 that includes a sleeve 816 defining a cavity 828 with a radial dimension D. In this embodiment, radial dimension D of cavity 828 is varied in a continuously decreasing manner over the axial length thereof, such that a generally tapered profile is exhibited. While the antenna assembly 800 includes a sleeve 816 defining a cavity 828 that is not compartmentalized into any regions, the tapered profile may be applicable to any of the embodiments disclosed herein above.

[0072] In another embodiment, seen in FIG. 11, an antenna assembly 900 is disclosed that includes one or more temperature sensors 994 coupled to a distal portion 902a of an inner conductor for monitoring a temperature fluctuation at or about the distal portion 902a. It may be desirable to monitor the temperature of the distal portion 902a, and/or the tissue that may come into contact therewith, or with sleeve 916, in an effort to guard against overheating and/or the unintended therapeutic effects on the tissue. This may be particularly useful in applications where microwave energy is used for treating or ablating tissue around the radiating portion. In alternate embodiments, temperature sensors 994 may be coupled or otherwise incorporated into antenna assembly 900 at any suitable location, including, but not being limited to sleeve 916, such that the temperature of the distal portion 902a of the inner conductor and/or the cavity 928 may be monitored. In various embodiments, temperature sensor or sensors 994 may be located on the sleeve 916, e.g., on an external surface thereof, or within the sleeve 916, e.g., within the cavity 928 which the sleeve 916 defines, using any suitable means, e.g. adhesives. The temperature sensor or sensors 994 may be located on a baffle member or members 942, 944, if any. Temperature sensors 994 may be configured for electrical connection to power source 20 (FIG. 1).

[0073] The temperature sensor or sensors 994 may be a semiconductor-based sensor, a thermister, a thermocouple or other temperature sensor that would be considered as suitable by one skilled in the art. An independent temperature monitor (not shown) may be coupled to the temperature sensor. Alternatively, a power supply with an integrated temperature monitoring circuit (not shown), such as one described in U.S. Pat. No. 5,954,719, may be used to modulate microwave power output supplied to the antenna assembly. Other physiological signals, e.g. EKG, may also be monitored by other medical instrumentation well known to one skilled in the art and such data applied to control the microwave energy delivered to the antenna assembly.

[0074] A closed loop control mechanism, such as a feedback controller with a microprocessor, may be implemented for controlling the delivery of energy, e.g., microwave energy, to the target tissue based on temperature measured by the temperature sensor or sensors 994.

[0075] Although the illustrative embodiments of the present disclosure have been described herein with reference to the accompanying drawings, the above description, disclosure, and figures should not be construed as limiting, but merely as exemplifications of particular embodiments. It is to be understood, therefore, that the disclosure is not limited to those precise embodiments, and that various other changes and modifications may be effected therein by one skilled in the art without departing from the scope or spirit of the disclosure.

Claims

What is claimed is:

1. A microwave ablation probe, comprising:

a tubular elongated member defining a longitudinal axis and having proximal and distal ends and inner and outer surfaces, the tubular elongated member further including a plurality channels defined in the inner surface thereof;

an outer conductor disposed along the longitudinal axis within the tubular elongated member;

a dielectric material disposed coaxially within the outer conductor;

an antenna disposed coaxially within the dielectric material, the antenna extending distally from a distal end of the outer conductor, the antenna comprising:

an inner conductor disposed coaxially within the dielectric material; and

a cooling sleeve disposed coaxially about a distal portion of the inner conductor having a cooling chamber defined therein;

at least one inflow conduit in fluid communication with the cooling chamber and configured to deliver coolant thereto; and

at least one outflow conduit in fluid communication with the cooling chamber and configured to remove coolant therefrom.

2. The microwave ablation probe according to claim 1, wherein the plurality of channels are defined along the longitudinal axis of the tubular elongated member.

3. The microwave ablation probe according to claim 1, wherein at least one of the plurality of channels is configured to receive the at least one inflow conduit.

4. The microwave ablation probe according to claim 1, wherein at least one of the plurality of channels is configured to receive the at least one outflow conduit.

5. The microwave ablation probe according to claim 1, wherein the cooling chamber includes a baffle radially separating the cooling chamber into a first cooling region and a second cooling region.

6. The microwave ablation probe in accordance with claim 5, wherein the at least one inflow conduit includes a first inflow conduit in fluid communication with the first cooling region and a second inflow conduit in fluid communication with the second cooling region; and the at least one outflow conduit includes a first outflow conduit in fluid communication with the first cooling region and a second outflow conduit in fluid communication with the second cooling region.

7. The microwave ablation probe in accordance with claim 1, further including at least one temperature sensor configured to sense a temperature of the antenna.

8. The microwave ablation probe in accordance with claim 1, wherein the cooling sleeve is formed from a substantially rigid material.

9. The microwave ablation probe in accordance with claim 1, wherein the cooling sleeve is formed from a substantially non-rigid material.

10. A microwave ablation probe, comprising:

a tubular elongated member defining a longitudinal axis and having proximal and distal ends and inner and outer surfaces, the tubular elongated member including a plurality of channels defined in the inner surface thereof;

an outer conductor disposed along the longitudinal axis within the tubular elongated member;

a dielectric material disposed coaxially within the outer conductor;

an inner conductor disposed coaxially within the dielectric material;

an antenna disposed coaxially within the elongated member and wherein the antenna member extends distally from the elongated member, the antenna assembly including a cooling sleeve having a plurality of cooling chambers disposed coaxially about the inner conductor;

a plurality of inflow conduits disposed within at least one of the plurality of channels, each one of the plurality of inflow conduits in fluid communication with a corresponding one of the plurality of cooling chambers;

a plurality of outflow conduits disposed within at least one of the plurality of channels, each one of the plurality of outflow conduits in fluid communication with a corresponding one of the plurality of cooling chambers; and

a plurality of temperature sensors, each one of the plurality of temperature sensors associated with a corresponding one of the plurality of cooling chambers and configured to sense a temperature thereof.

11. The microwave ablation probe in accordance with claim 10, wherein the plurality of cooling chambers are separated by at least one baffle radially positioned therebetween.

12. The microwave ablation probe in accordance with claim 11, wherein the baffle is configured to substantially prevent fluid communication between the plurality of cooling chambers.

13. The microwave ablation probe in accordance with claim 10, wherein a first of the plurality of cooling chambers includes a first longitudinal dimension and a second of the plurality of cooling chambers includes a second longitudinal dimension that is different from the first longitudinal dimension.

14. The microwave ablation probe in accordance with claim 10, wherein a first of the plurality of cooling chambers includes a first radial dimension and a second of the plurality of cooling chambers includes a second radial dimension that is different from the first radial dimension.

Patent Citations (234)

Patent	Date	Inventor	Cited By
USD223367(S)	1972-04-01	Kountz	Applicant
USD263020(S)	1982-02-01	Rau, III	Applicant
USD266842(S)	1982-11-01	Villers et al.	Applicant
USD278306(S)	1985-04-01	McIntosh	Applicant
USD295893(S)	1988-05-01	Sharkany et al.	Applicant
USD295894(S)	1988-05-01	Sharkany et al.	Applicant
US5370675(A)	1994-12-01	Edwards et al.	Applicant
USD354218(S)	1995-01-01	Van de Peer	Applicant
US5458597(A)	1995-10-01	Edwards et al.	Applicant
US5472441(A)	1995-12-01	Edwards et al.	Applicant
US5486183(A)	1996-01-01	Middleman et al.	Applicant
US5536240(A)	1996-07-01	Edwards et al.	Applicant
US5549644(A)	1996-08-01	Lundquist et al.	Applicant
US5569242(A)	1996-10-01	Lax et al.	Applicant
US5688267(A)	1997-11-01	Panescu et al.	Applicant
US5741225(A)	1998-04-01	Lax et al.	Applicant
US5776176(A)	1998-07-01	Rudie	Applicant
US5861021(A)	1999-01-01	Thome et al.	Applicant
US5871523(A)	1999-02-01	Fleischman et al.	Applicant
US5904690(A)	1999-05-01	Middleman et al.	Applicant
US5921982(A)	1999-07-01	Lesh et al.	Applicant
US6002968(A)	1999-12-01	Edwards	Applicant
US6053912(A)	2000-04-01	Panescu et al.	Applicant
USD424693(S)	2000-05-01	Pruter	Applicant
USD424694(S)	2000-05-01	Tetzlaff et al.	Applicant
USD425201(S)	2000-05-01	Tetzlaff et al.	Applicant
US6068629(A)	2000-05-01	Haissaguerre et al.	Applicant
US6071281(A)	2000-06-01	Burnside et al.	Applicant
US6146379(A)	2000-11-01	Fleischman et al.	Applicant
US6165172(A)	2000-12-01	Farley et al.	Applicant
US6179832(B1)	2001-01-01	Jones et al.	Applicant
US6280441(B1)	2001-08-01	Ryan	Applicant
USD449886(S)	2001-10-01	Tetzlaff et al.	Applicant
USD457958(S)	2002-05-01	Dycus et al.	Applicant
USD457959(S)	2002-05-01	Tetzlaff et al.	Applicant
US6419653(B2)	2002-07-01	Edwards et al.	Applicant
US6471659(B2)	2002-10-01	Eggers et al.	Applicant
US6514249(B1)	2003-02-01	Maguire et al.	Applicant
US6547788(B1)	2003-04-01	Maguire et al.	Applicant
US6610054(B1)	2003-08-01	Edwards et al.	Applicant
US6622731(B2)	2003-09-01	Daniel et al.	Applicant
US6663624(B2)	2003-12-01	Edwards et al.	Applicant
US6682526(B1)	2004-01-01	Jones et al.	Applicant
USD487039(S)	2004-02-01	Webster et al.	Applicant
US6689126(B1)	2004-02-01	Farley et al.	Applicant
US6786905(B2)	2004-09-01	Swanson et al.	Applicant
USD496997(S)	2004-10-01	Dycus et al.	Applicant
USD499181(S)	2004-11-01	Dycus et al.	Applicant
US6852091(B2)	2005-02-01	Edwards et al.	Applicant
US6869431(B2)	2005-03-01	Maguire et al.	Applicant
US6893419(B2)	2005-05-01	Noda et al.	Applicant
US6918907(B2)	2005-07-01	Kelly et al.	Applicant
US6974463(B2)	2005-12-01	Magers et al.	Applicant
USD525361(S)	2006-07-01	Hushka	Applicant
US7108696(B2)	2006-09-01	Daniel et al.	Applicant
USD531311(S)	2006-10-01	Guerra et al.	Applicant
USD533942(S)	2006-12-01	Kerr et al.	Applicant
USD535027(S)	2007-01-01	James et al.	Applicant
USD541418(S)	2007-04-01	Schechter et al.	Applicant
US7207989(B2)	2007-04-01	Pike, Jr. et al.	Applicant
USD541938(S)	2007-05-01	Kerr et al	Applicant
US7226446(B1)	2007-06-01	Mody et al.	Applicant
US7258690(B2)	2007-08-01	Sutton et al.	Applicant
US7285116(B2)	2007-10-01	de la Rama et al.	Applicant
US7293562(B2)	2007-11-01	Malecki et al.	Applicant
US7294127(B2)	2007-11-01	Leung et al.	Applicant
US7300438(B2)	2007-11-01	Falwell et al.	Applicant
US7311703(B2)	2007-12-01	Turovskiy et al.	Applicant
US7335198(B2)	2008-02-01	Eggers et al.	Applicant
USD564662(S)	2008-03-01	Moses et al.	Applicant
US7387626(B2)	2008-06-01	Edwards et al.	Applicant
US7399299(B2)	2008-07-01	Daniel et al.	Applicant
USD576932(S)	2008-09-01	Strehler	Applicant
US7465300(B2)	2008-12-01	Arless et al.	Applicant
USD594736(S)	2009-06-01	Esjunin	Applicant
USD594737(S)	2009-06-01	Kelly et al.	Applicant
USD606203(S)	2009-12-01	Husheer et al.	Applicant
USD613412(S)	2010-04-01	DeCarlo	Applicant
US7799019(B2)	2010-09-01	Turovskiy et al.	Applicant
USD634010(S)	2011-03-01	DeCarlo	Applicant
US8012148(B2)	2011-09-01	Turovskiy et al.	Applicant
US8068921(B2)	2011-11-01	Prakash et al.	Applicant
US8192423(B2)	2012-06-01	Turovskiy et al.	Applicant
US8473077(B2)	2013-06-01	Bonn et al.	Applicant
US8491580(B2)	2013-07-01	Prakash et al.	Applicant
US2004/0181216(A1)	2004-09-01	Kelly et al.	Applicant
US2005/0010095(A1)	2005-01-01	Stewart et al.	Applicant
US2005/0222558(A1)	2005-10-01	Baxter et al.	Applicant
US2006/0015162(A1)	2006-01-01	Edward et al.	Applicant
US2006/0106375(A1)	2006-05-01	Werneth et al.	Applicant
US2006/0259024(A1)	2006-11-01	Turovskiy et al.	Applicant
US2007/0043337(A1)	2007-02-01	McAuley	Applicant
US2007/0083193(A1)	2007-04-01	Werneth et al.	Applicant
US2007/0179496(A1)	2007-08-01	Swoyer et al.	Applicant
US2007/0203480(A1)	2007-08-01	Mody et al.	Applicant
US2007/0213703(A1)	2007-09-01	Naam et al.	Applicant
US2007/0219546(A1)	2007-09-01	Mody et al.	Applicant
US2007/0255276(A1)	2007-11-01	Sliwa et al.	Applicant
US2007/0265610(A1)	2007-11-01	Thapliyal et al.	Applicant
US2007/0270789(A1)	2007-11-01	Berger	Applicant
US2007/0293854(A1)	2007-12-01	Pless et al.	Applicant
US2007/0293855(A1)	2007-12-01	Sliwa et al.	Applicant
US2008/0082093(A1)	2008-04-01	Prakash et al.	Applicant
US2008/0154259(A1)	2008-06-01	Gough et al.	Applicant
US2008/0281322(A1)	2008-11-01	Sherman et al.	Applicant
US2010/0057074(A1)	2010-03-01	Roman et al.	Applicant
US2010/0318078(A1)	2010-12-01	Turovskiy et al.	Applicant
US2012/0041433(A1)	2012-02-01	Prakash et al.	Applicant
US2012/0172860(A1)	2012-07-01	Brannan	Applicant
US2012/0172861(A1)	2012-07-01	Brannan	Applicant
US2012/0172862(A1)	2012-07-01	Brannan	Applicant
US2012/0172863(A1)	2012-07-01	Brannan	Applicant
US2012/0232544(A1)	2012-09-01	Willyard et al.	Applicant
US2012/0232549(A1)	2012-09-01	Willyard et al.	Applicant
US2012/0232619(A1)	2012-09-01	Turovskiy et al.	Applicant
US2013/0030429(A1)	2013-01-01	Rusin	Applicant
US2013/0041362(A1)	2013-02-01	Lee et al.	Applicant
US2013/0041365(A1)	2013-02-01	Rusin et al.	Applicant
US2013/0053695(A1)	2013-02-01	Brannan	Applicant
US2013/0067725(A1)	2013-03-01	Behnke, II et al.	Applicant
US2013/0072920(A1)	2013-03-01	Behnke, II et al.	Applicant
US2013/0072921(A1)	2013-03-01	Behnke, II et al.	Applicant
US2013/0072922(A1)	2013-03-01	Behnke, II et al.	Applicant
US2013/0072923(A1)	2013-03-01	Behnke, II et al.	Applicant
US2013/0079765(A1)	2013-03-01	Kim et al.	Applicant
US2013/0085488(A1)	2013-04-01	Brannan et al.	Applicant
US2013/0103025(A1)	2013-04-01	Brannan	Applicant
US2013/0103029(A1)	2013-04-01	Brannan	Applicant
US2013/0126207(A1)	2013-05-01	Rossetto et al.	Applicant
US2013/0131670(A1)	2013-05-01	Prakash	Applicant
US2013/0178841(A1)	2013-07-01	Reid, Jr.	Applicant
US2013/0178842(A1)	2013-07-01	Reid, Jr.	Applicant
US2013/0178843(A1)	2013-07-01	Lee et al.	Applicant
US2013/0178844(A1)	2013-07-01	Lee et al.	Applicant
US2013/0190751(A1)	2013-07-01	Brannan	Applicant
US2013/0192063(A1)	2013-08-01	Brannan	Applicant
US2013/0218143(A1)	2013-08-01	Ross	Applicant
US2013/0226172(A1)	2013-08-01	Peterson et al.	Applicant
CN1103807(A)	1995-06-01		Applicant
DE390937(C)	1924-03-01		Applicant
DE1099658(B)	1961-02-01		Applicant
DE1139927(B)	1962-11-01		Applicant
DE1149832(B)	1963-06-01		Applicant
DE1439302(A1)	1969-01-01		Applicant
DE2439587(A1)	1975-02-01		Applicant
DE2455174(A1)	1975-05-01		Applicant
DE2407559(A1)	1975-08-01		Applicant
DE2415263(A1)	1975-10-01		Applicant
DE2429021(A1)	1976-01-01		Applicant
DE2460481(A1)	1976-06-01		Applicant
DE2602517(A1)	1976-07-01		Applicant
DE2504280(A1)	1976-08-01		Applicant
DE2627679(A1)	1977-01-01		Applicant
DE2540968(A1)	1977-03-01		Applicant
DE2820908(A1)	1978-11-01		Applicant
DE2803275(A1)	1979-08-01		Applicant
DE2823291(A1)	1979-11-01		Applicant
DE2946728(A1)	1981-05-01		Applicant
DE3143421(A1)	1982-05-01		Applicant
DE3045996(A1)	1982-07-01		Applicant
DE3120102(A1)	1982-12-01		Applicant
DE3510586(A1)	1986-10-01		Applicant
DE3604823(A1)	1987-08-01		Applicant
DE8712328(U1)	1988-02-01		Applicant
DE3711511(C1)	1988-06-01		Applicant
DE3904558(A1)	1990-08-01		Applicant
DE3942998(A1)	1991-07-01		Applicant
DE4238263(A1)	1993-05-01		Applicant
DE4303882(C2)	1995-02-01		Applicant
DE4339049(A1)	1995-05-01		Applicant
DE29616210(U1)	1996-11-01		Applicant
DE19608716(C1)	1997-04-01		Applicant
DE19751106(A1)	1998-05-01		Applicant
DE19717411(A1)	1998-11-01		Applicant
DE19751108(A1)	1999-05-01		Applicant
DE19801173(C1)	1999-07-01		Applicant
DE19848540(A1)	2000-05-01		Applicant
DE10224154(A1)	2003-12-01		Applicant
DE10310765(A1)	2004-09-01		Applicant
DE10328514(B3)	2005-03-01		Applicant
DE102004022206(A1)	2005-12-01		Applicant
DE202005015147(U1)	2006-02-01		Applicant
DE102009015699(A1)	2010-05-01		Applicant
EP246350(A1)	1987-11-01		Applicant
EP521264(A2)	1993-01-01		Applicant
EP556705(A1)	1993-08-01		Applicant
EP558429(A1)	1993-09-01		Applicant
EP648515(A1)	1995-04-01		Applicant
EP667126(A1)	1995-08-01		Applicant
EP836868(A2)	1998-04-01		Applicant
EP882955(A1)	1998-12-01		Applicant
EP893101(A2)	1999-01-01		Applicant
EP1159926(A2)	2001-12-01		Applicant
EP1186274	2006-04-01		Applicant
EP1905375(A1)	2008-04-01		Applicant
EP2253286(A1)	2010-11-01		Applicant
FR179607	1906-11-01		Applicant
FR1275415(A)	1961-11-01		Applicant
FR1347865(A)	1964-01-01		Applicant
FR2235669(A1)	1975-01-01		Applicant
FR2276027(A1)	1976-01-01		Applicant
FR2313708(A1)	1976-12-01		Applicant
FR2502935(A1)	1982-10-01		Applicant
FR2517953(A1)	1983-06-01		Applicant
FR2573301(A1)	1986-05-01		Applicant
FR2862813(A1)	2005-05-01		Applicant
FR2864439(A1)	2005-07-01		Applicant
JP5-5106	1993-01-01		Applicant
JP5-40112	1993-02-01		Applicant
JP6343644(A)	1994-12-01		Applicant
JP7265328(A)	1995-10-01		Applicant
JP8056955(A)	1996-03-01		Applicant
JP8252263(A)	1996-10-01		Applicant
JP9000492(A)	1997-01-01		Applicant
JP9010223(A)	1997-01-01		Applicant
JP11244298(A)	1999-09-01		Applicant
JP2000342599(A)	2000-12-01		Applicant
JP2000350732(A)	2000-12-01		Applicant
JP2001003776(A)	2001-01-01		Applicant
JP2001008944(A)	2001-01-01		Applicant
JP2001029356(A)	2001-02-01		Applicant
JP2001037775(A)	2001-02-01		Applicant
JP2001128990(A)	2001-05-01		Applicant
JP2001231870(A)	2001-08-01		Applicant
JP2008142467(A)	2008-06-01		Applicant
SU166452	1964-11-01		Applicant
SU401367(A1)	1973-10-01		Applicant
SU727201(A2)	1980-04-01		Applicant
WO97/06739(A2)	1997-02-01		Applicant
WO97/06740(A2)	1997-02-01		Applicant
WO97/06855(A2)	1997-02-01		Applicant
WO/36985(A2)	2000-06-01		Applicant
WO2005/112783(A1)	2005-12-01		Applicant
WO2010/035831(A1)	2010-04-01		Applicant

Non-Patent Literature (132)

U.S. Appl. No. 13/835,183, filed Mar. 15, 2013 Arts.Applicant
U.S. Appl. No. 13/835,513, filed Mar. 15, 2013 Brannan.Applicant
U.S. Appl. No. 13/836,014, filed Mar. 15, 2013 Arts.Applicant
U.S. Appl. No. 13/836,353, filed Mar. 15, 2013 Arts.Applicant
U.S. Appl. No. 13/839,562, fFiled Mar. 15, 2013 Zheng.Applicant
U.S. Appl. No. 13/853,363, filed Mar. 29, 2013 Kim.Applicant
U.S. Appl. No. 13/867,834, filed Jul. 22, 2013 Brannan.Applicant
U.S. Appl. No. 13/871,142, filed Apr. 26, 2013 Ohri.Applicant
U.S. Appl. No. 13/886,080, filed May 2, 2013 Bahney.Applicant
U.S. Appl. No. 13/889,989, filed May 8, 2013 Lee.Applicant
U.S. Appl. No. 13/903,668, filed May 28, 2013 Podhajsky.Applicant
U.S. Appl. No. 13/904,478, filed May 29, 2013 Ohri.Applicant
U.S. Appl. 13/908,463, filed Jun. 3, 2013 Brannan.Applicant
U.S. Appl. No. 13/908,555, filed Jun. 3, 2013 Dunning.Applicant
U.S. Appl. No. 13/920,367, filed Jun. 18, 2013 Sharonov.Applicant
U.S. Appl. No. 13/920,411, filed Jun. 18, 2013 Sharonov.Applicant
U.S. Appl. No. 13/922,006, filed Jun. 19, 2013 Nau.Applicant
U.S. Appl. No. 13/942,833, filed Jul. 16, 2013 Sharonov.Applicant
U.S. Appl. No. 13/942,864, filed Jul. 16, 2013 Sharonov.Applicant
U.S. Appl. No. 13/943,452, filed Jul. 16, 2013 Behnke.Applicant
U.S. Appl. No. 13/945,519, filed Jul. 18, 2013 Prakash.Applicant
U.S. Appl. No. 13/945,718, filed Jul. 18, 2013 Rossetto.Applicant
U.S. Appl. No. 13/957,087, filed Aug. 1, 2013 Brannan.Applicant
U.S. Appl. No. 13/973,543, filed Aug. 22, 2013 Orszulak.Applicant
U.S. Appl. No. 14/011,414, filed Aug. 27, 2013 Ohri.Applicant
U.S. Appl. No. 14/011,438, filed Aug. 27, 2013 Ohri.Applicant
U.S. Appl. No. 14/014,937, filed Aug. 30, 2013 Willyard.Applicant
Jarrett et al., “Use of the LigaSure.TM. Vessel Sealing System for Peri-Hilar Vessels in Laparoscopic Nephrectomy” Sales/Product Literature 2000.Applicant
Johnson et al., “Evaluation of a Bipolar Electrothermal Vessel Sealing Device in Hemorrhoidectomy” Sales/Product Literature, Jan. 2004.Applicant
Johnson, “Evaluation of the LigaSure.TM. Vessel Sealing System in Hemorrhoidectormy” American College of Surgeons (ACS) Clinic La Congress Poster (2000).Applicant
Johnson et al., “New Low-Profile Applicators for Local Heating of Tissues”, IEEE Transactions on Biomedical Engineering, vol. BME-31, No. 1, Jan. 1984, pp. 28-37.Applicant
Johnson, “Use of the LigaSure.TM. Vessel Sealing System in Bloodless Hemorrhoidectomy” Innovations That Work, Mar. 2000.Applicant
Joseph G. Andriole M.D. et al., “Biopsy Needle Characteristics Assessed in the Laboratory”, Radiology 148: 659-662, Sep. 1983.Applicant
Joseph Ortenberg, “LigaSure.TM. System Used in Laparoscopic 1st and 2nd Stage Orchiopexy” Innovations That Work, Nov. 2002.Applicant
Kennedy et al., “High-burst-strength, feedback-controlled bipolar vessel sealing” Surgical Endoscopy (1998) 12: 876-878.Applicant
Kopans, D.B. et al., (Nov. 1985) “Spring Hookwire Breast Lesion Localizer: Use with Rigid-Compression. Mammographic Systems,” Radiology 157(2):537-538.Applicant
Koyle et al., “Laparoscopic Palomo Varicocele Ligation in Children and Adolescents” Pediatric Endosurgery & Innovative Techniques, vol. 6, No. 1, 2002.Applicant
LigaSure.TM. Vessel Sealing System, the Seal of Confidence in General, Gynecologic, Urologic, and Laparaoscopic Surgery, Sales/Product Literature, Jan. 2004.Applicant
Livraghi et al., (1995) “Saline-enhanced RF Tissue Ablation in the Treatment of Liver Metastases”, Radiology, p. 140 (Abstr).Applicant
Lyndon B. Johnson Space Center, Houston, Texas, “Compact Directional Microwave Antenna for Localized Heating,” NASA Tech Briefs, Mar. 2008.Applicant
M. A. Astrahan, “A Localized Current Field Hyperthermia System for Use with 192-Iridium Interstitial Implants” Medical Physics. 9(3), May/Jun. 1982.Applicant
Magdy F. Iskander et al., “Design Optimization of Interstitial Antennas”, IEEE Transactions on Biomedical Engineering, vol. 36, No. 2, Feb. 1989, pp. 238-246.Applicant
McGahan et al., (1995) “Percutaneous Ultrasound-guided Radiofrequency Electrocautery Ablation of Prostate Tissue in Dogs”, Acad Radiol, vol. 2, No. 1: pp. 61-65.Applicant
McLellan et al., “Vessel Sealing for Hemostasis During Pelvic Surgery” Int'l Federation of Gynecology and Obstetrics Figo World Congress 2000, Washington, DC.Applicant
MDTECH product literature (Dec. 1999) “FlexStrand”: product description, 1 page.Applicant
MDTECH product literature (Mar. 2000) I'D Wire: product description, 1 page.Applicant
Medtrex Brochure “The O.R. Pro 300” 1 page, Sep. 1998.Applicant
Michael Choti, “Abdominoperineal Resection with the LigaSure.TM. Vessel Sealing System and LigaSure.TM. Atlas 20 cm Open Instrument” Innovations That Work, Jun. 2003.Applicant
Muller et al., “Extended Left Hemicolectomy Using the LigaSure.TM. Vessel Sealing System” Innovations That Work. LJ, Sep. 1999.Applicant
Murakami, R. et al., (1995). “Treatment of Hepatocellular Carcinoma: Value of Percutaneous Microwave Coagulation,” American Journal of Radiology (AJR) 164:1159-1164.Applicant
Ni Wei et al., “A Signal Processing Method for the Coriolis Mass Flowmeter Based on a Normalized . . . ” Journal of Applied Sciences.cndot.Yingyong Kexue Xuebao, Shangha CN, vol. 23, No. 2: (Mar. 2005); pp. 160-184.Applicant
Ogden, “Goertzel Alternative to the Fourier Transform” Jun. 1993 pp. 485-487 Electronics World; Reed Business Publishing, Sutton, Surrey, BG, vol. 99, No. 9, 1687.Applicant
Olsson M.D. et al., “Radical Cystectomy in Females” Current Surgical Techniques in Urology, vol. 14, Issue 3, 2001.Applicant
Organ, L W., “Electrophysiologic Principles of Radiofrequency Lesion Making” Appl. Neurophysiol, vol. 39: pp. 69-76 (1976/77).Applicant
P.R. Stauffer et al., “Interstitial Heating Technologies”, Thermoradiotheray and Thermochemotherapy (1995) vol. I, Biology, Physiology, Physics, pp. 279-320.Applicant
Palazzo et al., “Randomized clinical trial of LigaSure.TM. versus open haemorrhoidectomy” British Journal of Surgery 2002, 89, 154-157 “Innovations in Electrosurgery” Sales/Product Literature; Dec. 31, 2000.Applicant
Paul G. Horgan, “A Novel Technique for Parenchymal Division During Hepatectomy” The American Journal of Surgery, vol. 181, No. 3, Apr. 2001, pp. 236-237.Applicant
Peterson et al., “Comparison of Healing Process Following Ligation with Sutures and Bipolar Vessel Sealing” Surgical Technology International (2001).Applicant
R. Gennari et al., (Jun. 2000) “Use of Technetium-99m-Labeled Colloid Albumin for Preoperative and Intraoperative Localization of Non palpable Breast Lesions,” American College of Surgeons. 190(6):692-699.Applicant
Valleylab Brochure, “Reducing Needlestick Injuries in the Operating Room” 1 page, Mar. 2001.Applicant
Reidenbach, (1995) “First Experimental Results with Special Applicators for High-Frequency Interstitial Thermotherapy”, Society Minimally Invasive Therapy, 4(Suppl 1):40 (Abstr).Applicant
Richard Wolf Medical Instruments Corp. Brochure, “Kleppinger Bipolar Forceps & Bipolar Generator” 3 pages, Jan. 1989.Applicant
Rothenberg et al., “Use of the LigaSure.TM. Vessel Sealing System in Minimally Invasive Surgery in Children” Int'l Pediatric Endosurgery Group (I PEG) 2000.Applicant
Sayfan et al., “Sutureless Closed Hemorrhoidectomy: A New Technique” Annals of Surgery, vol. 234, No. 1, Jul. 2001, pp. 21-24.Applicant
Sengupta et al., “Use of a Computer-Controlled Bipolar Diathermy System in Radical Prostatectomies and Other Open Urological Surgery” Anz Journal of Surgery (2001) 71.9 pp. 538-540.Applicant
Sigel et al., “The Mechanism of Blood Vessel Closure by High Frequency Electrocoagulation” Surgery Gynecology & Obstetrics, Oct. 1965 pp. 823-831.Applicant
Solbiati et al., (2001) “Percutaneous Radio-frequency Ablation of Hepatic Metastases from Colorectal Cancer: Long-term Results in 117 Patients”, Radiology, vol. 221, pp. 159-166.Applicant
Solbiati et al. (1995) “Percutaneous US-guided RF Tissue Ablation of Liver Metastases: Long-term Follow-up”, Radiology, pp. 195-203.Applicant
Strasberg et al., “Use of a Bipolar Vassel-Sealing Device for Parenchymal Transection During Liver Surgery” Journal of Gastrointestinal Surgery, vol. 6, No. 4, Jul./Aug. 2002 pp. 569-574.Applicant
Sugita et al., “Bipolar Coagulator with Automatic Thermocontrol” J. Neurosurg., vol. 41, Dec. 1944, pp. 777-779.Applicant
Sylvain Labonte et al., “Monopole Antennas for Microwave Catheter Ablation”, IEEE Trans. on Microwave Theory and Techniques, vol. 44, No. 10, pp. 1832-1840, Oct. 1995.Applicant
T. Matsukawa et al., “Percutaneous Microwave Coagulation Therapy in Liver Tumors”, Acta Radiologica, vol. 38, pp. 410-415, 1997.Applicant
T. Seki et al., (1994) “Ultrasonically Guided Percutaneous Microwave Coagulation Therapy for Small Hepatocellular Carcinoma,” Cancer 74(3):817.825.Applicant
Urologix, Inc.—Medical Professionals: Targis.TM. Technology (Date Unknown). “Overcoming the Challenge” located at: <http://www.urologix.com!medicaUtechnology.html> Nov. 18, 1999; 3 pages.Applicant
Urrutia et al., (1988). “Retractable-Barb Needle for Breast Lesion Localization: Use in 60 Cases,” Radiology 169 (3):845-847.Applicant
Valleylab Brochure, “Valleylab Electroshield Monitoring System” 2 pages, Nov. 1995.Applicant
ValleyLab Brochure, “Electosurgery: A Historical Overview”, Innovations in Electrosurgery, 1999.Applicant
Vallfors et al., “Automatically Controlled Bipolar Electrocoagulation-‘COA-COMP’” Neurosurgical Review 7:2-3 (1984) pp. 187-190.Applicant
W. Scott Helton, “LigaSure.TM. Vessel Sealing System: Revolutionary Hemostasis Product for General Surgery” Sales/Product Literature 1999.Applicant
Wald et al., “Accidental Burns”, JAMA, Aug. 16, 1971, vol. 217, No. 7, pp. 916-921.Applicant
Walt Boyles, “Instrumentation Reference Book”, 2002, Butterworth-Heinemann, pp. 262-264.Applicant
Wonnell et al., “Evaluation of Microwave and Radio Frequency Catheter Ablation in a Myocardium-Equivalent Phantom Model”, IEEE Transactions on Biomedical Engineering, vol. 39, No. 10, Oct. 1992; pp. 1086-1095.Applicant
U.S. Appl. No. 08/136,098, filed Oct. 14, 1993 Roger A. Stern.Applicant
U.S. Appl. No. 08/483,742, filed Jun. 7, 1995, Roger A. Stern.Applicant
U.S. Appl. No. 13/419,981, filed Mar. 14, 2012, Joseph D. Brannan.Applicant
U.S. Appl. No. 13/430,810, filed Mar. 27, 2012, Joseph D. Brannan.Applicant
U.S. Appl. No. 13/440,690, filed Apr. 5, 2012, Joseph D. Brannan.Applicant
U.S. Appl. No. 13/460,440, filed Apr. 30, 2012, Arnold V. DeCarlo.Applicant
U.S. Appl. No. 13/464,021, filed May 4, 2012, Joseph D. Brannan.Applicant
U.S. Appl. No. 13/477,260, filed May 22, 2012, William R. Reid, Jr.Applicant
U.S. Appl. No. 13/477,320, filed May 22, 2012, Joseph D. Brannan.Applicant
U.S. Appl. No. 13/711,086, filed Dec. 11, 2012, Brannan.Applicant
Alexander et al., “Magnetic Resonance Image-Directed Stereotactic Neurosurgery: Use of Image Fusion with Computerized Tomography to Enhance Spatial Accuracy” Journal Neurosurgery, 83 (1995), pp. 271-276.Applicant
Anderson et al., “A Numerical Study of Rapid Heating for High Temperature Radio Frequency Hyperthermia” International Journal of Bio-Medical Computing, 35 (1994), pp. 297-307.Applicant
Anonymous. (1999) Auto Suture MIBB Site Marker: Single Use Clip Applier, United States Surgical (Product instructions), 2 pages.Applicant
Anonymous. (2001) Disposable Chiba Biopsy Needles and Trays, Biopsy and Special Purpose Needles Cook Diagnostic and Interventional Products Catalog (products list), 4 pages.Applicant
Anonymous. (1987) Homer Mammalok.TM. Breast Lesion Needle/Wire Localizer, Namic.RTM. Angiographic Systems Division, Glens Falls, New York, (Hospital products price list), 4 pages.Applicant
Anonymous. (1999) MIBB Site Marker, United States Surgical (Sales brochure), 4 pages.Applicant
Anonymous. Blunt Tubes with Finished Ends. Pointed Cannula, Popper & Sons Biomedical Instrument Division, (Products Price List), one page, Jul. 19, 2000.Applicant
Anonymous. Ground Cannulae, ISPG, New Milford, CT, (Advertisement) one page, Jul. 19, 2000.Applicant
B. Levy M.D. et al., “Randomized Trial of Suture Versus Electrosurgical Bipolar Vessel Sealing in Vaginal Hysterectomy” Obstetrics & Gynecology, vol. 102, No. 1, Jul. 2003.Applicant
B. Levy M.D. et al., “Update on Hysterectomy New Technologies and Techniques” OBG Management, Feb. 2003.Applicant
B. Levy M.D., “Use of a New Vessel Ligation Device During Vaginal Hysterectomy” FIGO 2000, Washington, D.C.Applicant
B. F. Mullan et al., (May 1999) “Lung Nodules: Improved Wire for CT-Guided Localization,” Radiology 211:561-565.Applicant
B. T. Heniford M.D. et al., “Initial Research and Clinical Results with an Electrothermal Bipolar Vessel Sealer” Oct. 1999.Applicant
Bergdahl et al., “Studies on Coagulation and the Development of an Automatic Computerized Bipolar Coagulator” Journal of Neurosurgery 75:1 (Jul. 1991), pp. 148-151.Applicant
Bulletin of the American Physical Society, vol. 47, No. 5, Aug. 2002, p. 41.Applicant
C. F. Gottlieb et al., “Interstitial Microwave Hyperthermia Applicators having Submillimetre Diameters”, Int. J. Hyperthermia, vol. 6, No. 3, pp. 707-714, 1990.Applicant
C. H. Dumey et al., “Antennas for Medical Applications”, Antenna Handbook: Theory Application and Design, p. 24-40, Van Nostrand Reinhold, 1988 New York, V.T. Lo, S.W. Lee.Applicant
Carbonell et al., “Comparison of the Gyrus PlasmaKinetic Sealer and the Valleylab LigaSure.TM. Device in the Hemostasis of Small, Medium, and Large-Sized Arteries” Carolinas Laparoscopic and Advanced Surgery Program, Carolinas Medical Center, Charlotte, NC 2003.Applicant
Carus et al., “Initial Experience With the LigaSure.TM. Vessel Sealing System in Abdominal Surgery” Innovations That Work, Jun. 2002.Applicant
Chicharo et al., “A Sliding Goertzel Algorithm” Aug. 1996 DOS pp. 283-297 Signal Processing, Elsevier Science Publishers B.V. Amsterdam, NL, vol. 52, No. 3.Applicant
Chou, C.K., (1995) “Radiofrequency Hyperthermia in Cancer Therapy,” Chapter 941n Biologic Effects of Nonionizing Electromagnetic Fields, CRC Press, Inc., pp. 1424-1428.Applicant
Chung et al., “Clinical Experience of Sutureless Closed Hemorrhoidectomy with LigaSure.TM.” Diseases of the Colon & Rectum, vol. 46, No. 1, Jan. 2003.Applicant
Cosman et al., “Methods of Making Nervous System Lesions” In William RH, Rengachary SS (eds): Neurosurgery, New York: McGraw.cndot.Hill, vol. 111, (1984), pp. 2490-2499.Applicant
Cosman et al., “Radiofrequency Lesion Generation and its Effect on Tissue Impedence”, Applied Neurophysiology, 51:230-242, 1988.Applicant
Cosman et al., “Theoretical Aspects of Radiofrequency Lesions in the Dorsal Root Entry Zone” Neurosurgery 15: (1984), pp. 945-950.Applicant
Crawford et al., “Use of the LigaSure.TM. Vessel Sealing System in Urologic Cancer Surger” Grand Rounds in Urology 1999, vol. 1, Issue 4, pp. 10-17.Applicant
Dulemba et al., “Use of a Bipolar Electrothermal Vessel Sealer in Laparoscopically Assisted Vaginal Hysterectomy” Sales/Product Literature; Jan. 2004.Applicant
E. David Crawford, “Evaluation of a New Vessel Sealing Device in Urologic Cancer Surgery” Sales/Product Literature 2000.Applicant
E. David Crawford, “Use of a Novel Vessel Sealing Technology in Management of the Dorsal Veinous Complex” Sales/ Product Literature 2000.Applicant
Esterline, “Light Key Projection Keyboard” Advanced Input Systems, located at: <http://www.advanced-input.com/lightkey> 2002.Applicant
Esterline Product Literature, “Light Key: Visualize a Virtual Keyboard. One With No Moving Parts”, Nov. 1, 2003; 4 pages.Applicant
Geddes et al., “The Measurement of Physiologic Events by Electrical Impedence” Am. J. Ml, Jan. Mar. 1964, pp. 16-27.Applicant
Goldberg et al., “Image-guided Radiofrequency Tumor Ablation: Challenges and Opportunities—Part I”, (2001) J Vasc. Interv. Radio!, vol. 12, pp. 1021-1032.Applicant
Goldberg et al. (1995) “Saline-enhanced RF Ablation: Demonstration of Efficacy and Optimization of Parameters”, Radiology, 197(P): 140 (Abstr).Applicant
Goldberg et al., “Tissue Ablation with Radiofrequency: Effect of Probe Size, Gauge, Duration, and Temperature on Lesion Volume” Acad Radio (1995) vol. 2, No. 5, pp. 399-404.Applicant
H. Schwarzmaier et al., “Magnetic Resonance Imaging of Microwave Induced Tissue Heating” Dept. of Laser Medicine & Dept. of Diagnostic Radiology; Heinrich-Heine-University, Duesseldorf, Germany; Dec. 8, 1994; pp. 729-731.Applicant
Heniford et al., “Initial Results with an Electrothermal Bipolar Vessel Sealer” Surgical Endoscopy (2001) 15:799-801.Applicant
Herman at al., “Laparoscopic Intestinal Resection With the LigaSure.TM. Vessel Sealing System: A Case Report” Innovations That Work, Feb. 2002.Applicant
Humphries Jr. et al., “Finite Element Codes to Model Electrical Heating and Non.cndot.Llnear Thermal Transport in Biological Media”, Proc. ASME HTD-355, 131 (1997).Applicant
Ian D. McRury et al., The Effect of Ablation Sequence and Duration on Lesion Shape Using Rapidly Pulsed Radiofrequency Energy Through Electrodes, Feb. 2000, Springer Netherlands, vol. 4; No. 1, pp. 307-320.Applicant

Abstract